Literature DB >> 17317935

Immunohistochemical expression of Mina53 and Ki67 proteins in human primary gingival squamous cell carcinoma.

Keitaro Kuratomi1, Hirohisa Yano, Makoto Tsuneoka, Kikuo Sakamoto, Jingo Kusukawa, Masamichi Kojiro.   

Abstract

Studies have reported the presence of relationships between the Myc target gene Mina53 and poor prognostic factors in several cancers including esophageal cancer. In this study, we investigated the relationships between Mina53 expression in gingival squamous cell carcinoma and clinicopathological factors. Seven samples of normal and dysplastic gingival tissues and 15 samples of gingival squamous cell carcinoma were immunostained for Mina53 and Ki67, and examined for the relationships between their expression and differentiation degree, lymph node metastasis, stage, tumor diameter, and prognosis. In normal and dysplastic gingival tissues, the localization of the expression of Mina53 and Ki67 was similar, but that in gingival squamous cell carcinoma tissue varied depending on the degree of differentiation. In well-differentiated GSCC with pearl formation, Mina53 was negative at the center of the clearly keratinized cancer nest, but positive in the nuclei of cells in the periphery and adjacent area of the cancer nest. In diffusely proliferating undifferentiated and moderately-differentiated GSCC showing no pearl formation, both Mina53 tended to be positive in the nuclei of cancer cells in the entire cancer nest. A significant correlation was found between the expression of Mina53 and that of Ki67 in patients with gingival squamous cell carcinoma or dysplastic gingiva. No significant correlation was noted between the expression of Mina53 or Ki67 and prognostic factors such as the degree of differentiation, lymph node metastasis, stage, and tumor diameter. In gingival squamous cell carcinoma, Mina53 expression was correlated with the proliferation of tumor cells, but unlike esophageal and other squamous cell carcinomas, not with the prognosis. The absence of correlations with prognostic factors suggests that may differ gingival squamous cell carcinoma differs biologically from esophageal squamous cell carcinoma which is correlated with Mina53 in terms of the biological expression of Mina53.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17317935     DOI: 10.2739/kurumemedj.53.71

Source DB:  PubMed          Journal:  Kurume Med J        ISSN: 0023-5679


  17 in total

1.  Upregulated expression of Mina53 in cholangiocarcinoma and its clinical significance.

Authors:  Xiao-Ping Tan; Qing Zhang; Wei-Guo Dong; Xia-Wen Lei; Zi-Rong Yang
Journal:  Oncol Lett       Date:  2012-02-28       Impact factor: 2.967

Review 2.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

3.  Mdig, a lung cancer-associated gene, regulates cell cycle progression through p27(KIP1).

Authors:  Dan Ma; Dan Guo; Wei Li; Hongwen Zhao
Journal:  Tumour Biol       Date:  2015-04-09

4.  Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study.

Authors:  S Humayun; V Ram Prasad
Journal:  Natl J Maxillofac Surg       Date:  2011-01

5.  Oncoprotein mdig contributes to silica-induced pulmonary fibrosis by altering balance between Th17 and Treg T cells.

Authors:  Chitra Thakur; Michael Wolfarth; Jiaying Sun; Yadong Zhang; Yongju Lu; Lori Battelli; Dale W Porter; Fei Chen
Journal:  Oncotarget       Date:  2015-02-28

6.  Paradoxical roles of mineral dust induced gene on cell proliferation and migration/invasion.

Authors:  Miaomiao Yu; Jiaying Sun; Chitra Thakur; Bailing Chen; Yongju Lu; Hongwen Zhao; Fei Chen
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

Review 7.  Current understanding of mdig/MINA in human cancers.

Authors:  Chitra Thakur; Fei Chen
Journal:  Genes Cancer       Date:  2015-07

8.  Mdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin.

Authors:  Bailing Chen; Miaomiao Yu; Qingshan Chang; Yongju Lu; Chitra Thakur; Danjun Ma; Zhenping Yi; Fei Chen
Journal:  Oncotarget       Date:  2013-09

9.  Transcriptional activation of Mina by Sp1/3 factors.

Authors:  Shangli Lian; Hari Hara S K Potula; Meenu R Pillai; Melanie Van Stry; Madoka Koyanagi; Linda Chung; Makiko Watanabe; Mark Bix
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

10.  Potential effects of Mina53 on tumor growth in human pancreatic cancer.

Authors:  Xiao-ping Tan; Wei-guo Dong; Qing Zhang; Zi-rong Yang; Xiao-fei Lei; Ming-hua Ai
Journal:  Cell Biochem Biophys       Date:  2014-07       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.